American Brivision (ABVC) SEC Filing S-1 IPO report for the period ending Thursday, April 8, 2021

SEC Filings

ABVC Registration of Securities

    S-1 Registration of Securities April 2023
  • S-1 Registration of Securities April 2021
  • S-1 Registration of Securities November 2020

American Brivision

CIK: 743532 Ticker: ABVC

View differences made from one to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this S-1 Registration of Securities to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Brivision.


Assess how American Brivision's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Ticker: ABVC
CIK: 1173313
Form Type: S-1 Registration of Securities
Accession Number: 0001213900-21-020698
Submitted to the SEC: Wed Apr 07 2021 5:52:07 PM EST
Accepted by the SEC: Thu Apr 08 2021
Period: Thursday, April 8, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: